Nature Reviews Drug Discovery 13, 217–236 (2014)
The name of one of the authors — Kian Hoe Khoo — was incorrectly ordered in the published version. This has now been corrected in the online version.
Additional information
The online version of the original article can be found at 10.1038/nrd4236
Rights and permissions
About this article
Cite this article
Khoo, K., Verma, C. & Lane, D. Erratum: Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov 13, 314 (2014). https://doi.org/10.1038/nrd4288
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4288
This article is cited by
-
The essential role of TAp73 in bortezomib-induced apoptosis in p53-deficient colorectal cancer cells
Scientific Reports (2017)
-
Characterizing the conformational landscape of MDM2-binding p53 peptides using Molecular Dynamics simulations
Scientific Reports (2017)
-
Enhancing Specific Disruption of Intracellular Protein Complexes by Hydrocarbon Stapled Peptides Using Lipid Based Delivery
Scientific Reports (2017)
-
New Phage Display-Isolated Heptapeptide Recognizing the Regulatory Carboxy-Terminal Domain of Human Tumour Protein p53
The Protein Journal (2017)
-
Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma
Molecular Therapy - Oncolytics (2016)
